Newsletter January 2019 No.189
Top News
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
On November 21, 2018, the "Pharmaceutical Association of Japan President Press Conference" was held at the Nihonbashi Life Science Hub (Chuo-ku, Tokyo). At this press conference, which was held in addition to the "Regular Press Conference" (held in May and January of each fiscal year), Yuzuru Nakayama, Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), explained the challenges facing the pharmaceutical industry and its mid- to long-term proposals (first report). The press conference was attended by 34 members of the media, who engaged in a lively exchange of questions.
Topics
- Japan-U.S.-Europe Pharmaceutical Association Collaborative Project "Facts and Figures on Drug Discovery Research and the Contribution of Innovation
- Revision of the "Pharmaceutical Manufacturers Association of Japan Charter of Corporate Behavior" and "Pharmaceutical Manufacturers Association of Japan Compliance Program Guidelines
- Held the 3rd Meeting of Code Officials
- BioJapan 2018 and APAC Natural Products Drug Discovery Consortium Signing Ceremony (Thailand, Taiwan, Japan)
- The "Pharmaceutical Manufacturers Association of Japan (PMAJ) Press Tour" Held
- The 33rd Public Relations Seminar
- The 6th Taiwan-Japan Pharmaceutical Exchange Conference held
- The 7th ICH Association Meeting "ICH Charlotte Conference" was held
- Government-Private Sector Mission to China Held
- The 20th Symposium of the Pharmaceutical Quality Forum held
- The 22nd Technical Workshop on Energy Saving and Global Warming Countermeasures" was held
Policy Research Institute page
Explanation
From JPMA
Medium- and Long-term Proposals from the Pharmaceutical Manufacturers' Association (First Report)
Information
- Personnel Changes in the Pharmaceutical Manufacturers Association of Japan
- Major Activity Reports and Planned Activities
- The medical information program "Iryojin Yakushin Yume no Meditemple 2019 Special" is being broadcast by popular demand!
- Publications
- Publications
- 2019 Life Science Intellectual Property Forum